AAAAAA

   
Results: 1-11 |
Results: 11
A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge
Authors: Patterson, LJ Robey, F Muck, A Van Remoortere, K Aldrich, K Richardson, E Alvord, WG Markham, PD Cranage, M Robert-Guroff, M
Citation: Lj. Patterson et al., A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge, AIDS RES H, 17(9), 2001, pp. 837-849
A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: Anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells
Authors: Robey, FA Robert-Guroff, M
Citation: Fa. Robey et M. Robert-guroff, A defined conformational epitope from the C4 domain of HIV type 1 glycoprotein 120: Anti-cyclic C4 antibodies from HIV-positive donors magnify glycoprotein 120 suppression of interleukin 2 produced by T cells, AIDS RES H, 17(6), 2001, pp. 533-541
Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1and CD4 down-regulation
Authors: Peng, B Robert-Guroff, M
Citation: B. Peng et M. Robert-guroff, Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1and CD4 down-regulation, IMMUNOL LET, 78(3), 2001, pp. 195-200
IgG surfaces as an important component in mucosal protection
Authors: Robert-Guroff, M
Citation: M. Robert-guroff, IgG surfaces as an important component in mucosal protection, NAT MED, 6(2), 2000, pp. 129-130
CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees
Authors: Leno, M Kowalski, M Robert-Guroff, M
Citation: M. Leno et al., CD8 T cell anti-HIV activity as a complementary protective mechanism in vaccinated chimpanzees, AIDS, 14(7), 2000, pp. 893-894
Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques
Authors: Patterson, LJ Peng, B Abimiku, AG Aldrich, K Murty, L Markham, PD Kalyanaraman, VS Alvord, WG Tartaglia, J Franchini, G Robert-Guroff, M
Citation: Lj. Patterson et al., Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques, AIDS, 14(16), 2000, pp. 2445-2455
Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo
Authors: Margolis, L Glushakova, S Chougnet, C Shearer, G Markham, P Robert-Guroff, M Benveniste, R Miller, CJ Cranage, M Hirsch, V Franchini, G
Citation: L. Margolis et al., Replication of simian immunodeficiency virus (SIV) in ex vivo lymph nodes as a means to assess susceptibility of macaques in vivo, VIROLOGY, 275(2), 2000, pp. 391-397
In pursuit of a human breast cancer virus, from mouse to human
Authors: Robert-Guroff, M Buehring, GC
Citation: M. Robert-guroff et Gc. Buehring, In pursuit of a human breast cancer virus, from mouse to human, INFEC DIS S, 2000, pp. 475-487
CD8(+) lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy
Authors: Leno, M Carter, L Venzon, DJ Romano, J Markham, PD Limbach, K Tartaglia, J Paoletti, E Benson, J Franchini, G Robert-Guroff, M
Citation: M. Leno et al., CD8(+) lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: Potential role in vaccine efficacy, AIDS RES H, 15(5), 1999, pp. 461-470
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251
Authors: Buge, SL Murty, L Arora, K Kalyanaraman, VS Markham, PD Richardson, ES Aldrich, K Patterson, LJ Miller, CJ Cheng, SM Robert-Guroff, M
Citation: Sl. Buge et al., Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251, J VIROLOGY, 73(9), 1999, pp. 7430-7440
Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251 (vol 73, pg 7430, 1999)
Authors: Buge, SL Murty, L Arora, K Kalyanaraman, VS Markham, PD Richardson, ES Aldrich, K Patterson, LJ Miller, CJ Cheng, SM Robert-Guroff, M
Citation: Sl. Buge et al., Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251 (vol 73, pg 7430, 1999), J VIROLOGY, 73(11), 1999, pp. 9692-9692
Risultati: 1-11 |